Form 4: Amgen SVP & CCO Nancy A. Grygiel Reports Acquisition of Common Stock

Nancy A. Grygiel, SVP & CCO of Amgen, reports acquiring 1,503 shares of common stock and holding 8,713 shares directly, along with indirect ownership through the 401(k) plan.

Summary

• On March 3, 2025, Nancy A. Grygiel, SVP & CCO of Amgen, acquired 1,503 shares of Amgen common stock.
• The acquisition was made at a price of $0 per share.
• Following the transaction, Grygiel directly owns 8,713 shares of Amgen common stock.
• Grygiel also indirectly owns shares through the company's 401(k) plan, totaling 102.2192 shares.
• The shares include 114 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a transaction by an insider. The acquisition of shares by an executive is generally viewed as a positive sign, but without additional context, the impact is limited.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies like Amgen.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates confidence from a company executive.

Key Dates